Experimental Serotonergic Agents for the Treatment of Schizophrenia

Schizophrenia remains one of the most chronic and highly disabling mental disorder. To date, the pathomechanism of schizophrenia is not fully understood and current treatments are characterized by some limitations. First- and second-generation antipsychotics have shown clinical efficacy in treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Capuzzi, Enrico, Caldiroli, Alice, Ciscato, Veronica, Russo, Stefania, Buoli, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872893/
https://www.ncbi.nlm.nih.gov/pubmed/33574716
http://dx.doi.org/10.2147/JEP.S259317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872893/
https://www.ncbi.nlm.nih.gov/pubmed/33574716
http://dx.doi.org/10.2147/JEP.S259317

Ejemplares similares